Article

AI-based Cancer Models for Prediction of Antibody-Drug Conjugate (ADC) Response in Oncology

2025-09-24

Abstract excerpt

Artificial intelligence (AI) has been influencing the way oncology has been practiced. Major issues constituting a bottleneck are the lack of data for training purposes, confidentiality preventing development, or the absence of transparency in clarifying how models operate to generate decisions. With explainable AI, trust and utilization barriers among clinicians, researchers, and patients can be removed. With the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0bfd2757-ee4f-580e-93e3-9e1b0f54e658
DOI: 10.20944/preprints202509.2027.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

AI-based Cancer Models for Prediction of Antibody-Drug Conjugate (ADC) Response in OncologyDOI 10.20944/preprints202509.2027.v1Read

Future AI Will Be Able to Predict Antibody-Drug Conjugate Response in OncologySemantic proximity Read

AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosisSemantic proximity Read

Immunotherapy Efficacy Prediction in Cancer: An Artificial Intelligence Approach with Unannotated H&E Whole-Slide ImagesSemantic proximity Read

Artificial Intelligence (AI) and Machine Learning (ML) in Diagnosing Cancer: Current TrendsSemantic proximity Read

Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challengesSemantic proximity Read

Artificial Intelligence in Immune Checkpoint Inhibitor Research: A Bibliometric Analysis of the LandscapeSemantic proximity Read

Artificial intelligence assists precision medicine in cancer treatmentSemantic proximity Read

Integrating Artificial Intelligence with Genomic and Biomarker Data for the Advancement of Personalized Therapeutics in a Human-Centric FrameworkSemantic proximity Read

Clinical Potential of Antibody–Drug Conjugates in Early-Phase Clinical Trials for Late-Line Treatment of Advanced Solid TumorsSemantic proximity Read

Towards Precision Oncology: How Advances in Cancer Genomics, Immunobiology and Artificial Intelligence Will Change Molecular DiagnosticsSemantic proximity Read

Endocrine Therapy Recommendation for Estrogen Receptor Positive (ER + ) Metastases Advanced Breast Cancer using Machine Learning AlgorithmsSemantic proximity Read

Artificial intelligence in tumor drug resistance: Mechanisms and treatment prospectsSemantic proximity Read